Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilaprisan PK and DDI with Itraconazole in Healthy Postmenopausal Women
NCT02456129Phase 1Completed
- Sponsor
- Bayer
- Start
- Jul 2015
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of vilaprisan in Uterine Fibroids (UF), sponsored by Bayer. Primary endpoints: Area under the concentration time curve and Maximum plasma concentration up to 14 days. Started Jul 2015; status: completed.
02
Drugs
vilaprisan
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT02456129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02456129.